Oestrogen plays a permissive role in cardioprotection

Cardiovascular Research

Volumn 79, Issue 3, 2008, Pages 353-354

  Cohen, Michael V ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIOCTANOIN; ESTROGEN; PLACEBO; PROTEIN KINASE C;

ANGINA PECTORIS; BRAIN INFARCTION SIZE; DEEP VEIN THROMBOSIS; EDITORIAL; ESTROGEN THERAPY; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; ISOLATED HEART; LUNG EMBOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPERFUSION; SIGNAL TRANSDUCTION; TREATMENT FAILURE;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG IMPLANTS; ESTRADIOL; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OVARIECTOMY; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; PROTEIN TRANSPORT; RATS; SIGNAL TRANSDUCTION;

EID: 48749085913     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn152     Document Type: Editorial

References (19)

1. Cohen MV, Downey JM. Ischemic preconditioning: description, mechanism, and significance. In: Sperelakis N, Kurachi Y, Terzic A, Cohen MV, eds. Heart Physiology and Pathophysiology. 4th ed. San Diego, Academic Press; 2001. 867-885
2. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995;91:291-297.
3. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997;77:314-318.
4. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
5. Cohen MV, Downey JM. Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol 2008;103:203-215.
6. ATP channels. Circ Res 2001;89:273-278.
7. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447-452.
8. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605- 613.
9. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-534.
10. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SAA, Black H et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
11. Shinmura K, Nagai M, Tamaki K, Bolli R. Loss of ischaemic preconditioning in ovariectomized rat hearts: possible involvement of impaired protein kinase C ε phosphorylation. Cardiovasc Res 2008;79:387-394.
12. Chen C-H, Mochly-Rosen D. Opposing effects of δ and εPKC in ethanol-induced cardioprotection. J Mol Cell Cardiol 2001;33:581- 585.
13. Inagaki K, Hahn HS, Dorn GW II, Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and ε-protein kinase C activator. Circulation 2003;108:869-875.
14. Murriel CL, Churchill E, Inagaki K, Szweda LI, Mochly-Rosen D. Protein kinase Cδ activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem 2004;279:47985-47991.
15. Ping P, Zhang J, Qiu Y, Tang X-L, Manchikalapudi S, Cao X et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 1997;81:404-414.
16. Rezkalla SH, Kloner RA. Ischemic preconditioning and preinfarction angina in the clinical arena. Nat Clin Pract Cardiovasc Med 2004;1:96-102.
17. Rezkalla SH, Kloner RA. Preconditioning in humans. Heart Fail Rev 2007;12:201-206.
18. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G et al. Long-term benefit of postconditioning. Circulation 2008;117:1037-1044.
19. + channel and protein kinase C activation. Basic Res Cardiol 2006;101:180- 189.